Metastatic Prostate Cancer Clinical Trials in Dallas, Texas
3 recruitingDallas, Texas
Showing 1–3 of 3 trials
Recruiting
Phase 3
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Novartis Pharmaceuticals450 enrolled142 locationsNCT05939414
Recruiting
Phase 1Phase 2
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Metastatic Prostate Cancer
AstraZeneca60 enrolled15 locationsNCT06267729
Recruiting
Phase 1
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Metastatic Prostate Cancer
ORIC Pharmaceuticals250 enrolled27 locationsNCT05413421